80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
Despite flat earnings and challenging market conditions, Cresco Labs Inc. CRLBF remains an “Overweight” stock, according to analysis firm Zuanic & Associates. In his latest report, Zuanic underscores Cresco’s strong positioning in emerging adult-use …